key: cord-0895179-5e9mxgfl authors: Singh, Romil; Shaik, Likhita; Mehra, Ishita; Kashyap, Rahul; Surani, Salim title: Novel and Controversial Therapies in COVID-19 date: 2020-12-31 journal: Open Respir Med J DOI: 10.2174/1874306402014010079 sha: 367ef52ce63bc9ce89479d986a08e30e69a79c4e doc_id: 895179 cord_uid: 5e9mxgfl The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19. In December 2019, an outbreak of pneumonia of unknown etiology was reported by the Wuhan Municipal Health Commission, in Wuhan, Hubei Province in China. Subsequently, novel coronavirus SARS CoV-2 was identified as the cause of the 2019 coronavirus disease (COVID-19) [1] . As the disease rapidly spread across borders and was proven difficult to contain, the World Health Organization (WHO) declared COVID-19 as a pandemic on March 11 th , 2020. On June 22, 2020, there were more than 9 Million positive patients worldwide, with >469,000 global deaths [2] . Typically, COVID-19 presents as fever, dry cough, and fatigue. It may also show other mild symptoms such as nasal congestion, headache, conjunctivitis, sore throat, diarrhea, anosmia, or discoloration of fingers or toes. Approximately 80% of the patients recover without needing hospital treatment; however, the remaining 20% may require hospitalization, some even advance to critical illness. Patients with pre-existing conditions such as hypertension, underlying chronic heart and lung diseases, diabetes, and cancer are at a higher risk of experiencing COVID-19 related complications, which could lead to a poorer prognosis [3] . It is a fact that the various vitamins, trace elements, herbal remedies, and probiotics enhance immunity during times when there is no definitive preventive or therapeutic cure for viral infections like COVID-19, especially in the pediatric age groups considering the lockdown states [4 -12] . Emergency Use Authorization (EUA) was issued on March 28th, 2020, by the Food and Drug Administration (FDA), which was later withdrawn based on the newer data. This sanction was for the use of oral formulations of hydroxychloroquine sulfate and chloroquine phosphate when recommended for the treatment of COVID-19 by a health care professional [13] . Likewise, the emergency use of antiviral drug Remdesivir for COVID-19 positive cases with the significant disease was warranted on May 1, 2020 [14] . In this time of uncertainty in several countries, non-evidencebased novel therapies are deployed to improve patient outcomes. We aim to review these novels, yet controversial therapies that are being proposed and used in the treatment of COVID-19. Vitamin C (VC), also known as ascorbic acid, is known for its antioxidant properties. This characteristic of VC appears to play an essential role in modulating elevated levels of oxidative stress like infections and cancers. Infections lead to an activation of our immune system, which releases various oxidizing agents grouped as Reactive Oxygen Species (ROS). Though these ROS are useful to deactivate the microorganisms, they prove to be detrimental to the host cells [15] . The duration of mechanical ventilation is reduced by 14% in a recent trial among 685 patients with the use of VC. Another multi-centric study confirmed the reduction in ventilation time by 25% with the dosage of 1-6g/day of VC in patients treated in critical care [16 -18] . With a pandemic like COVID-19, additional safe, cost-effective, and immunesupportive strategies, such as VC, may be warranted to protect individuals and populations against developing a severe disease [19] . Thus, VC can be a potential prophylactic and therapeutic target for severe ARDS in COVID-19 patients [20] . Fowler et al. [21] and Wang et al. [22] suggested that VC has a therapeutic role in critically ill patients. Studies conducted by Hemilä et al. [23] and Messina et al. [24] point towards the promising nature of VC in effectively improving the morbidity and mortality of patients in regard to COVID-19. With the rise of epidemics like COVID-19, additional safe, cost-effective, and immune-supportive strategies, such as VC, may be warranted to protect individuals and populations against developing a severe disease [21 -26] . Furthermore, previous evidences of VC to reduce the ICU stay and morbidity of patients in critical care with conditions like ARDS, sepsis, burns, trauma and respiratory failure, give an opportunity to investigate the role of VC in similar situations related to . Though the studies differ in doses used in the treatment of critical patients with the coronavirus, VC definitely seems to improve the outcomes (Table 1) . The role of Vitamin D (VD) in providing immunity is unclear. The potential mechanisms include antiviral immunomodulation, induction of autophagy and apoptosis, and genetic or epigenetic regulation. Furthermore, the risk of viral infections can be reduced by VD. In addition, it has been observed in COVID-19 patients, that it works by enhancing the release of cytokines (pro-inflammatory) by the T helper type 2 cells, which will cause a diminution (anti-inflammatory) of the functioning of the T helper type 1 cells during various bacterial and viral crises [36, 37] . The high prevalence and outbreak of COVID during the winters raise the suspicion that there could be a relationship between VD deficiency and the infection leading to the high mortality rates in the elderly populations, who are known to produce lower amounts of VD, as compared to younger individuals when regularly exposed to sunlight [38] . Various studies have suggested that there exists a relationship between VD deficiency and COVID-19, thus suggesting it might act as an aid to decrease the fatal nature of the virus. Nair et al. and Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention interpret age as a risk factor for VD deficiency, which, if appropriately supplemented with VD, will improve COVID-19 outcomes. Similar studies report the association of low VD levels and positive blood cultures that might impact the severity of the condition [39 -44] . More studies need to define VD deficiency and groups prone to the deficit in relation to the coronavirus in order to prevent and cure it ( Table 2 ). Vitamin A (VA) is a fat-soluble compound, which plays an essential role in many physiological functions like embryonic development, vision, immunity, cellular differentiation, and proliferation [45, 46] . WHO stated in an article that VA supplementation improved the outcome of respiratory infections in nutritionally challenged children [47] . It is a fact that VA improves the clinical results in patients affected by measles associated pneumonia. However, some studies show that low doses of VA are associated with a low risk of respiratory infection [48] . Though these results have not been consistent, VA still does not have an established role in epidemics like COVID-19. VA seems to have an effective role in improving the morbidity of COVID-19 cases by alleviating the functions of neutrophils, natural killer cells, monocytes or macrophages, T cells, and B cells [49] . Therefore, the role of VA in COVID-19 treatment remains inconclusive. The European Micronutrients recommendations network of excellence (EURRECCA) has stated that selenium plays a crucial role in five significant functions like cognition individuals aged >50 years, viral load and onset of Acute Respiratory Distress Syndrome (AIDS) in Human Immunodeficiency Virus (HIV) positive patients, immune functions, male fertility, and cancer (particularly for persons at risk of prostate cancer) [50] . Supplementing a moderate dose of selenium can strengthen cellular immunity, humoral immunity, and nonspecific immunity. Thus, its deficiency can impair immunity and is a potential form of protection for the prevention and therapies of infections of the respiratory system [51] . Selenium is known for its remarkable redox biology when it comes to neutralizing the release of the reactive oxygen species in the reaction to infections in the body. Numerous studies indicated the implication of its deficiencies with the evolution of various infections, cancers, neurodegenerative diseases, and cardiovascular diseases [50] . With the rise of infections like COVID-19, it is possible to say that selenium can have a protective and therapeutic role in improving morbidity rates. Selenium had improved effects after an influenza vaccine challenge [52] . A correlation between low selenium levels and an increased risk of COVID-19 related mortality has been found in China, leading to worse outcomes [53] . Thus, blinded randomized controlled trials are needed to explore the correlation between COVID-19 and selenium. Dietary zinc deficiency in developing countries is widespread and often exacerbated by acute and chronic infections. It is a necessary component of numerous metalloproteins, including those critical for DNA replication and cell division, and is crucial for maintaining immunological integrity, predominantly cellular immunity and antioxidant activity. It is also associated with growth, impaired immunity, learning disabilities, and anorexia [54] . Studies show that children with Zinc deficiency are at an increased risk of respiratory tract infections. Many mechanisms have been implicated in the role of zinc deficiency in causing an increased susceptibility to Acute Respiratory Infections (ARI's). Zinc plays a vital barrier role in the cohesiveness of respiratory epithelial cells and controls the secretion of pro-inflammatory cytokines. Improved immunity has been confirmed with high dose Zinc supplementation for Torque Teno Virus (TTV) [55] . It is reported that Zinc supplementation could play a key role in preventing ARI in developing countries. It is supposed to lower the duration of respiratory tract infections, the number of episodes, the severity of bronchiolitis, and pneumonia [56] . But, this effect was minimal when other cases specific filters were applied [57] . Hence, the role of zinc in pandemics like COVID is unclear. "Probiotics" are live microorganisms that are supposed to be beneficial to the health and well-being of an individual when ingested or applied to the body. The Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) have described probiotics as "live microorganisms which confer a health benefit on the host when administered in adequate amounts" [58] . The most commonly used probiotics are Lactobacilli and Bifidobacteria strains, and the yeast Saccharomyces boulardii. Some reports contemplate the use of probiotics in COVID-19. In a recent study, Trompette et al. stated that improving the diet quality in a susceptible COVID-19 individual could mitigate the risk of significant infection and complications [59] . Morrow et al. [60] conducted randomized controlled trials and reported that critically ill patients on mechanical ventilation if given probiotics (i.e., live Bacillus subtilis, Lactobacillus rhamnosus GG, and Enterococcus faecalis) developed significantly less ventilator-associated pneumonia compared with the patients who were on placebo [60] . There is also an indication that probiotic strains maintain equilibrium between proinflammatory and immunoregulatory cytokines, which aid in viral clearance while reducing immune response-mediated lung damage, which might be of particular interest in preventing ARDS, a significant complication of COVID-19. An RCT with Lactobacillus Plantarum DR7 diminished plasma pro-inflammatory cytokines (IFN-π, TNF-α) in middle-aged adults (30 to 60 years of age) and boosted anti-inflammatory cytokines (IL-4, IL-10) in young adults (30 years of age), supplemented by reduction of plasma peroxidation and oxidative stress compared with placebo [61] . This finding might be helpful, as it shows to inhibit the cytokine storm occurring in COVID-19 patients. Lactobacillus acidophilus and Bacillus clausii in the animal study did not show any reduction in the expression of coronavirus receptors in the murine small intestine when compared with the control and the post-Salmonella infection models. Feng et al. conducted animal studies and found that coronaviruses receptors could increase in the presence of both invasive bacteria and their counterpart, probiotics (Lactobacillus acidophilus and Bacillus clausii) in the murine small intestine with control and postsalmonella infection models [62] . Due to a lack of substantial data, further clinical trials are warranted to understand the effect of probiotics in COVID-19. Polyunsaturated Fatty Acids (PUFA) are classified into two classes, the Omega-6 (N-6) family of PUFA (e.g., linoleic acid, arachidonic acid) and the Omega-3 (N-3) family (e.g., alpha-linolenic acid, Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA). Such distinct groups of fatty acids have been extensively studied to understand their effects on cardiovascular and metabolic health, and cancer [63] . It is recognized that ω-3 PUFAs have anti-inflammatory properties and play an essential role in the body's inflammation resolution [64] . In several lung infections, the administration of PUFA can improve the patient's outcome in acute pneumonia. Sharma et al. reported in their study that the dietary supplementation of ω-3 PUFA supplementation exerts an overall beneficial effect against acute experimental pneumonia. This mechanism is operative through the up-regulation of nonspecific and specific host immune defenses [65]. Jones et al. concluded the susceptibility of poxvirus infection of mice was not affected by dietary fats utilization [66] . Dushianthan et al. [67] examined the effects of omega-3 fatty acids and antioxidants in adults with ARDS (a significant complication in COVID-19). The study showed an ambiguity in regards to the consumption of omega-3 and other antioxidants and their benefits towards the improvement of ICU length of stay and duration of ventilator days. They further concluded that the intervention of omega-3 usage produced a minuscule or no difference in all-cause mortality [67] . Considering the scarcity of data on hand, we have to rely on the results of ongoing trials to establish the role of ω-3 supplementation in ARDS and COVID-19. Fowler III et al. [21] Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The Administration of approximately 15g/day of IV VC for 4 days may reduce the mortality rates in sepsis-related ARDS patients. A new randomized control trial (RCT) tests the effects of IV VC in viral infections in 140 patients. The study will investigate the effects of IV VC with a dose of 24g/day for 7 days vs. placebo. It will assess the requirements for mechanical ventilation and vasopressor drugs, organ failure scores, ICU length of stay, and 28day mortality. Hemilä et al. [ Critical cases after organ failure have decreased mortality by 16.5%, respiratory assistance requirements by 2.5 days, ICU stays by 3.2 days, and hospital admission by 6.7 days after VC administration. However, inflammatory markers failed to improve significantly during the CITRIS-ALI trial. Table 2 . Summary of the evidence outlining the potential role of Vitamin D in COVID-19. Wimalawansa, S.J. et al. [39] The global epidemic of coronavirus--COVID-19: What we can do to minimize risks 5000 IU/d. Individuals prone to COVID-19 need to have their VD levels more than 40-60ng/ml by supplementing 10,000IU/day for a few weeks followed by tapering to 5000IU/day. Nair et al. [40] Vitamin D: The "sunshine" vitamin Supportive data for the effective role of VD in decreasing the risk of COVID-19 could be highlighted by increased case-fatality rates with chronic disease comorbidity and age, in which lower concentrations of 25(OH) D have been reported. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention [41] . Since VD levels decrease with age, it may be important to assess the risk of VD as a factor owing to its high case fatality in older age groups. Grant et al. [42] Evidence that Vitamin D Supplementation Could Reduce the Risk of Influenza and COVID-19 Infections and Deaths Treatment of Community Acquired Pneumonia (CAP) with VD did not significantly result in complete resolution but led to decreased concentration of IL-6, CRP in diabetic patients. VD contributes to the increased risk of ARDS development. Moraes et al. [43] Lee et al. [44] 1. Vitamin D deficiency is independently associated with mortality among critically ill patients. 2. Vitamin D deficiency in critically ill patients. There may be an etiological association between low VD levels, positive blood cultures, and mortality in critically ill patients admitted to ICU. They reported in conclusion that flavonoids: Hesperidine, Naringin, and Epigallocatechin Gallate (EGCG), were potent inhibitors of the nCoV-SP receptor-binding domain of S protein (RBD). At the same time, Quercetin showed affinity to human receptor human angiotensin-converting enzyme-2 (ACE-2) and found to be more efficient towards the viral spike glycoprotein. Quercetin effectively blocked the human ACE-2 receptor by binding to a substantial residue ASP38 and hindered the formation of the salt bridge with LYS353 and, ultimately, the well-recognized hotspot LYS353, which is well recognized by SARS-CoV-2. Adem et al. [70] Bench/ Lab Study After Molecular docking, the study found that flavonoids like hesperidin and rutin may bind the main protease (Mpro) of COVID-19 better than Nelfinavir. Bhatia et al. [71] Bench/ Lab Study They performed Virtual Screening by Molecular Docking approach, which established the top 6 docked polyphenols, which are primarily derivatives of Sanguiin, Theaflavin, Kaempferol, Punicalagin, and Protocatechuic acid. Sanguiin and Theaflavin were proposed to resolve breathing difficulties in patients with extreme COVID-19, as they already are established bronchodilators. Ang et al. [72] Systematic review The team reviewed 12 pattern identifications, herbal compositions, and analyzed their herbal formulae, recommended by Chinese guidelines for the treatment of various pediatric COVID-19 stages. After thorough analysis, the herb Armeniacae semen was found to be most frequently used for the treatment of pediatric COVID-19 in the Chinese population. It reduced hyper-responsiveness in the airways and inhibited Th2 cells. Polyphenols are natural plant compounds and are generally involved in the defense against ultraviolet radiation or pathogenic aggression. Over the last decade, the possible health benefits of dietary plant polyphenols as an antioxidant have been of great interest. The main classes of polyphenols are phenolic acids, flavonoids, lignans, and stilbenes. Out of these, one of the most prominent phenols is the class flavonoids. The benefit of continuing the use of polyphenols against cancer growth, cardiovascular disorders, diabetes, osteoporosis, and neurodegenerative diseases was implied in recent epidemiological studies. Their key role in being anti-inflammatory, anti-mutagenic, antioxidant, and anti-carcinogenic is diverse [68] . The summary of the use of flavonoids and polyphenols in COVID-19 is exhibited in Table 3 . Bhowmick et al. [69] , and Adem et al. [70] reported the binding of flavonoids and polyphenols to the receptors of SARS-CoV-2, subsequently inhibiting it at a molecular level. They also proposed the affinity of flavonoids towards the ACE-2 receptor [69, 70] . Ang et al. [71] reported the use of Armeniacae semen, which was the most frequently used herbal supplement reducing the hyper-responsiveness on the airways for the treatment of pediatric COVID-19 in the Chinese population [71]. Bhatia et al. [72] suggested the use of "Black Tea," a theaflavin, in the routine diet as it is an inexpensive and easily accessible source of polyphenols. Polyphenols in black tea could potentially stop the replication and transmission of viruses and could be useful in the current health emergency state. The study suggested that patients quarantining at home with mild symptoms of COVID-19 can include these polyphenols in their diets. This dietary supplement could augment their physiological response against COVID-19. In-vitro testing should be conducted to assess the effectiveness of these polyphenols in the supportive treatment of COVID-19 [72] . Curcumin is a chemical with potent anti-inflammatory and antioxidant properties, popularly found in turmeric. These novel compounds have been proposed as an adjunctive therapy on social media. Jena et al. depicted the role of curcumin and catechin in binding to the S-protein at the location where host cell binding is known to occur. Similarly, they documented the attachment of these molecules to ACE2 sites that served as a viral entry medium. The study concluded that curcumin has the potential to block the entry of viral protein by inhibiting the host cell receptor and virus binding [73]. On 14 th April 2020, MGC pharmaceuticals announced the approval from the Human Research Ethics Committee ('Ethics Committee') of Nazareth Hospital EMMS in Israel to implement a Phase II placebo-controlled clinical trial to determine the safety and efficacy of a natural anti-infective formulation ('ArtemiC' or 'Product') in patients infected with COVID-19 [74]. Colloidal silver is composed of small silver particles in a liquid marketed as a dietary supplement claiming to have antiviral properties. There is, however, a shortage of evidence to support arguments related to its benefits. In reality, colloidal silver can be hazardous to one's health. Zachar et al. [75] concluded that successful Minimum Inhibitory Concentration (MIC) was achieved in both the bronchial tree and the alveoli after investigating its effect in specific locations of the respiratory system during viral and bacterial infections. They concluded that successful MIC was achieved in both the bronchial tree and the alveoli. This approach was proposed as a first-line treatment to suppress the progression of the SARS-COV-2 infection in the respiratory system [75] . Further studies are needed to support this hypothesis. Nutrition and immunity go hand in hand and are known to have a direct relationship in reducing the risk and severity of any infection. Various macro and micronutrients have been implicated to affect morbidity and mortality positively when supplemented during the episodes of infection. Since the COVID-19 pandemic constitutes higher mortality due to respiratory failure, these nutrients may have a beneficial but not completely validated role as a prophylactic and therapeutic treatment. However, there is insufficient data to prove an association between COVID-19 and the benefits of nutrition. There is also a clear need to study the beneficial effects' applicability on the whole population or only on the groups that are nutritionally challenged. Robust nutritional surveys and blinded randomized clinical studies are needed to investigate the potential effects of such therapies on COVID-19. Not applicable. None. The authors declare no conflict of interest, financial or otherwise. Johns Hopkins Coronavirus Resource [1] Center COVID-19 Map Contribution of selected [4] vitamins and trace elements to immune function Baseline serum vitamin A and D levels determine benefit of oral vitamin A&D supplements to humoral immune responses following pediatric influenza vaccination Prevention and treatment of influenza common cold by herbal, complementary, and natural therapies Nutraceuticals have potential for [7] boosting the type 1 interferon response to RNA viruses including influenza and coronavirus The effect of probiotics on [8] prevention of common cold: a meta-analysis of randomized controlled trial studies Enhancing immunity in viral infections, with special emphasis on COVID-19: A review Micronutrients and the pathogenesis of human [10] immunodeficiency virus infection Potential interventions for novel coronavirus in [11] China: A systematic review ESPEN expert statements [12] and practical guidance for nutritional management of individuals with SARS-CoV-2 infection Published Food and drug administration. Coronavirus (COVID-19) update: FDA [14] issues emergency use authorization for potential COVID-19 treatment 2020 How neutrophils kill microbes Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: A meta-regression analysis Vitamin C may reduce ventilation time in critically ill Optimal [19] nutritional status for a well-functioning immune system is an important factor to protect against viral infections COVID-19: A Possible Low-Cost Ally With a Wide Margin of Safety 2020 on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the citris-ali randomized clinical trial Effects of different ascorbic acid [22] doses on the mortality of critically ill patients: A meta-analysis Functional role of dietary [24] intervention to improve the outcome of COVID-19: A hypothesis of work A new clinical trial to test high-dose vitamin C in patients [25] with COVID-19 Can early and high intravenous dose of vitamin C prevent [26] and treat coronavirus disease 2019 (COVID-19 Vitamin C Can Shorten the Length [28] of Stay in the ICU: A Meta-Analysis Vitamin C supplementation [29] in the critically ill patient Hydrocortisone, vitamin c, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study ARDS complicating pustular psoriasis: Treatment [31] with low-dose corticosteroids, vitamin C and thiamine Ramesh natarajan [32] and alpha alsbury fowler. Vitamin C infusion for gastric acid aspiration-induced acute Respiratory Distress Syndrome (ARDS) Phase I safety trial of [33] intravenous ascorbic acid in patients with severe sepsis Myths in emergency medicine: Vitamin C trial lacks [34] answers for sepsis Vitamin C for Sepsis and Acute [35] Respiratory Failure regulation of T cells Vitamin D deficiency in adults: [37] when to test and how to treat Clinical features of patients infected [38] with 2019 novel coronavirus in Wuhan, China Maseeh A, Vitamin D. Vitamin D: The "sunshine" vitamin Xue Za Zhi. The epidemiological [41] characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19 D supplementation could reduce risk of influenza and COVID-19 infections and deaths Vitamin D deficiency [43] is independently associated with mortality among critically ill patients Vitamin D deficiency in critically ill [44] patients Vitamin a [45] metabolism, action, and role in skeletal homeostasis Vitamin A [46] Deficiency and the Lung Global action plan for prevention and control of Effects of dietary vitamin A [48] content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine Flattening the COVID-19 curve [49] with natural killer cell based immunotherapies selenium requirements for deriving dietary reference values The function of selenium on the infection of [51] respiratory system Selenium supplementation has [52] beneficial and detrimental effects on immunity to influenza vaccine in older adults Connection between selenium and COVID-19 outcomes [53] revealed in China analysis 2020 Zinc and infection: a review High-dose zinc oral [55] supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation Role of zinc supplementation in acute [56] respiratory tract infections in children aged 2 to 60 months Zinc supplementation for the [57] prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials Dietary fiber confers [59] protection against flu by shaping Ly6c -patrolling monocyte hematopoiesis and CD8 Probiotic prophylaxis of [60] ventilator-associated pneumonia: A blinded, randomized, controlled trial Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebocontrolled study The small intestine, an underestimated site of SARS-CoV-2 [62] infection: From red queen effect to probiotics Spite M. Resolution of acute inflammation and the role [64] of resolvins in immunity, thrombosis, and vascular biology Dietary supplementation [65] with omega-3 polyunsaturated fatty acids ameliorates acute pneumonia induced by Klebsiella pneumoniae in BALB/c mice The effects of diets enriched in omega-3 Immunonutrition for acute respiratory distress syndrome (ARDS) in adults Flavonoids: An overview Evaluation of flavonoids as 2019-[69] ncov cell entry inhibitor through molecular docking and pharmacological analysis 2020 COVID-19 Main Protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA Herbal medicine [71] for treatment of children diagnosed with COVID-19: A review of guidelines Repurposing old friends (food borne polyphenols) for new enemy Catechin and [73] Curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane: Insights from Computational study and implication for intervention Ethics committee approval received for phase ii clinical trial [74] on patients diagnosed with COVID-19 2020 Formulations for COVID-19 early stage treatment via silver [75] nanoparticles inhalation delivery at home and hospital science open preprints 2020 All the authors have seen and approved the manuscript, contributed significantly to the work of this manuscript, and also that the manuscript has not been previously published nor is not being considered for publication elsewhere.